Summary
Alcoholism is a source of enormous morbidity and mortality. Depressive disorders occur commonly in the course of alcoholism and affect its outcome. While the exact relationship of depression and alcoholism for most patients is controversial, it is probably heterogenous, with much depression resulting from the toxic effects of alcohol and at least some representing an independent disorder.
Studies to date have shown that antidepressant medication is efficacious both in patients who are alcohol dependent with primary depression, and who are alcohol dependent with secondary depression which persists during abstinence. Antidepressants are not effective in reducing drinking in nondepressed patients. Among depressed patients who are alcohol dependent, antidepressants appear to decrease drinking among those whose depression responds. In the case of selective serotonin reuptake inhibitors (SSRIs), one study suggests that they may possibly also decrease drinking by a direct mechanism. Currently, SSRIs appear to be the treatment of choice for patients who are alcohol dependent with comorbid depression.
Effective management of alcoholism with depression requires accurate syndromal diagnosis of depressive and other comorbid disorders. Ideally, this is done during a period of abstinence. Even when this is not possible, antidepressant treatment can be administered effectively. Careful monitoring and concurrent psychosocial treatment is essential for optimal outcomes. Treatment-resistant depression is managed as in non-comorbid cases. Treatment-resistant alcoholism may be managed by more intensive psychosocial treatment, addition of naltrexone, supervised disulfiram treatment or inpatient treatment. Future studies should further clarify the genetic relationship of the disorders and the optimal psychopharmacological and psychotherapeutic treatment strategies.
Similar content being viewed by others
References
Institute of Medicine. Causes and consequences of alcohol Problems. Washington, DC: National Academy Press, 1987
Murphy GE, Wetzel RD, Robins E, et al. Multiple risk factors predict suicide in alcoholism. Arch Gen Psychiatry 1992; 49: 459–63
Lowenfels AB, Wynn PS. One less for the road: international trends in alcohol consumption and vehicular fatalities. Ann Epidemiol 1992; 2(3): 249–56
Dufour MC. Death certificates as a data base for health research? Only with your help. Bull Pathol Educ 1984; 9(2): 57–9
Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area study. JAMA 1990; 264: 2511–9
Kessler RC, McGonagle KA, Camelley KB, et al. The epidemiology of psychiatric comorbidity. In: Tsaung M, Cohen M, Zahner G, editors. Textbook of psychiatric epidemiology. New York: John Wiley and Sons, 1996: 179–97
Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend 1995; 39: 197–206
Merikangas KR, Gelernter CS. Cormorbidity for alcoholism and depression. Psychiatr Clin North Am 1990; 13: 613–32
Coryell W, Endicottt J, Keller M. Major depression in a nonclinical sample. Arch Gen Psychiatry 1992; 49: 117–25
Rounsaville BJ, Dolinsky ZS, Babor TF, et al. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry 1987; 44: 505–13
Mueller TI, Lavori PW, Keller MB, et al. Prognostic effect of the variable course of alcoholism on the 10-year course of depression. Am J Psychiatry 1994; 151: 701–6
Hasin DS, Tsai WY, Endicott J, et al. The effects of major depression on alcoholism. Am J Addict 1996; 5(2): 144–55
Murphy GE, Armstrong JW, Hermele SL, et al. Suicide and alcoholism: interpersonal loss confirmed as a predictor. Arch Gen Psychiatry 1979; 36: 65–9
Schuckit MA, Winokur G. A short term follow-up of women alcoholics. Dis Nerv Sys 1972; 33: 672–8
Schuckit MA. The clinical implications of primary diagnostic groups among alcoholics. Arch Gen Psychiatry 1985; 42: 1043–9
Brown SA, Schuckit MA. Changes in depression among abstinent alcoholics. J Stud Alcohol 1988; 49: 412–7
Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985; 142(11): 1259–64
Quitkin FM, Rifkin A, Kaplan J, et al. Phobic anxiety syndrome complicated by drug dependence and addiction: a treatable form of drug abuse. Arch Gen Psychiatry 1972; 27: 159–62
Weiss RD, Griffin ML, Mirin SM. Drug abuse as self-medication for depression: an empirical study. Am J Drug Alcohol Abuse 1992; 18(2): 121–9
Cloninger CR, Reich T, Wetzel R. Alcoholism and affective disorders: familial association and genetic models. In: Goodwin DW, Erickson CK, editors. Alcoholism and affective disorders: clinical, genetic, and biochemical studies. New York: SP Medical and Scientific Books, 1979: 57–86
Merikangas KR, Gelernter CS. Comorbidity for alcoholism and depression. Psychiatr Clin North Am 1990; 13(4): 613–31
Kendler KS, Heath AC, Neale MC, et al. Alcoholism and major depression in women: a twin study of comorbidity. Arch Gen Psychiatry 1993; 50: 690–8
Merikangas KR, Risch NJ, Weissman MM. Comorbidity and co-transmission of alcoholism, anxiety, and depression. Psychol Med 1994; 24: 69–80
Schuckit MA. Alcoholism and affective disorder: diagnostic confusion. In: Goodwin DW, Erickson CK, editors. Alcoholism and affective disorders. New York: Spectrum, 1979: 9–20
Grant BF, Hasin DS, Dawson DA. The relationship between DSM-IV alcohol use disorders and DSM-IV major depression: examination of the primary-secondary distinction in a general population sample. J Affect Disord 1996; 38: 113–28
Deykin EY, Levy JC, Wells V. Adolescent depression, alcohol and drug abuse. Am J Public Health 1987; 77: 178–82
Heizer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 1988; 49: 219–24
Nunes EV, McGrath PJ, Quitkin FM, et al. Imipramine treatment of alcoholism with comorbid depression. Am J Psychiatry 1993; 150(6): 963–5
McGrath PJ, Nunes EV, Stewart JW, et al. Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial. Arch Gen Psychiatry 1996; 53: 232–40
Mason BJ, Kocsis JH, Ritvo EC, et al. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 1996; 275(10): 761–7
Ciraulo DA, Salloum IM, Cornelius MD, et al. Tricyclic antidepressants in the treatment of depression associated with alcoholism. J Clin Psychopharmacol 1981; 1: 146–50
Gorelick D. Serotonin uptake blockers and the treatment of alcoholism. In: Recent developments in alcoholism: treatment research, 7. New York: Plenum Press, 1989: 267–81
Naranjo C, Kadlec K, Sanhueza P, et al. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 1990; 47: 490–8
Amit Z, Brown Z, Sutherland A, et al. Reduction in alcohol intake in humans as a function of treatment with zimelidine: implications for treatment. In: riNaranjo C, Sellers E, editors. Research advances in new psychopharmacological treatments for alcoholism. Amsterdam: Exerpta Medica, 1985: 242–282
Kranzler HR, Burleson JA, Korner P, et al. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 1995; 152: 391–7
Cornelius JR, Salloum IM, Cornelius MD, et al. Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacol Bull 1993; 29: 195–9
Cornelius JR, Salloum IM, Cornelius MD, et al. Preliminary report: double-blind placebo-controlled study of fluoxetine in depressed alcoholics. Psychopharmacol Bull 1995; 31: 297–303
de Waele JP, Kiianmaa K, Gianoulakis C. Spontaneous and ethanol-stimulated in vitro release of beta endorphin by the hypothalamus of AA and ANA rats. Alcohol Clin Exp Res 1994; 18: 1468–73
Omalley SS, Jaffe AJ, Schottenfeld RS, et al. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 1992; 49: 881–7
Volpicelli JR, Alterman AI, Hayashida M, et al. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992; 49: 876–80
Brown SA, Inaba RK, Gillin JC, et al. Alcoholism and affective disorder: clinical course of depressive symptoms. Am J Psychiatry 1995; 152: 45–52
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association Press, 1994
Schuckit M. Alcoholic patients with secondary depression. Am J Psychiatry 1983; 140: 711–4
Schuckit MA. Drug and alcohol abuse: a clinical guide to diagnosis and treatment. 4th ed. New York: Plenum Medical Book Co., 1995
Hayashida M, Alterman AI, McLellan AT, et al. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. N Engl J Med 1989; 320(6): 358–65
Miller WR, Hester RK. The effectiveness of alcoholism treatment: what research reveals. In: Mill WR, Heather N, editors. Treating addictive behaviors: processes of change. New York: Plenum Press, 1986: 121–74
Kadden RM. Project MATCH: treatment main effects and matching results [abstract]. Alcohol Clin Exp Res 1996; 20(8): 196A-7A
O’Farrell T. Marital and family therapy. In: Reid HK, Miller W, editors. The handbook of alcoholism treatment approaches: effective alternatives. New York: Allyn & Bacon, 1995
Galanter M. Network therapy for addiction: a model for office practice. Am J Psychiatry 1993; 150(1): 28–36
Dorus W, Ostrow DG, Anton R, et al. Lithium treatment of depressed and nondepressed alcoholics. JAMA 1989; 262: 1646–52
Beresford TP, Blow FC, Hill E, et al. Comparison of CAGE questionnaire and computer-assisted laboratory profiles in screening for covert alcoholism. Lancet 1990; 336: 482–5
Beresford TP, Low D, Hall RC, et al. A computerized biochemical profile for detection of alcoholism. Psychosomatics 1982; 23(7): 713–4, 719–20
Bernadt MW, Taylor C, Mumford J, et al. Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet 1982; I(8267): 325–8
Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991; 37(12): 2029–37
Anton R, Moak DH, Latham P. Carbohydrate-deficient transferrin as an indicator of drinking status during a treatment outcome study. Alcohol Clin Exp Res 1996; 20(5): 841–6
Kapur BM, Israel Y. Alcohol dipstick — a rapid method for analysis of ethanol in body fluids. In: Chang NC, Chao HM, editors. Early identification of alcohol abuse, research monograph no. 17. Rockville (MD): DHHS Publications, 1985: 1–30
Nunes EV, Deliyannides D, Donovan S, et al. The management of treatment resistance in depressed patients with substance use disorders. Psychiatr Clin North Am 1996; 19(2): 311–27
Fuller RK, Branchey L, Brightwell DR, et al. Disulfiram treatment of alcoholism: a Veterans Administration cooperative study. JAMA 1986; 256: 1449–55
O’Farrel T, Bayog R. Antabuse contracts for married alcoholics and their spouses: a method to maintain antabuse ingestion and decrease conflict about drinking. J Subst Abuse Treat 1986; 3: 1–8
Azrin N, Sisson R, Meyers R, et al. Alcoholism treatment by disulfiram and community reinforcement therapy. Behav Ther Exp Psychiatry 1982; 13(2): 105–12
Littleton J. Acamprosate in alcohol dependence: how does it work? Addiction 1995; 90: 1179–
Paille FM, Guelfi JD, Perkins AC, et al. Double-blind randomized multicenter trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol 1995; 30: 239–47
Author information
Authors and Affiliations
Additional information
About the Author: Patrick J. McGrath, MD, is Associate Professor of Clinical Psychiatry, Columbia University College of Physicians and Surgeons, New York, USA, and Associate Psychiatrist at the New York State Psychiatric Institute. Dr McGrath is currently the principal investigator of a study of fluoxetine in the treatment of drepressed alcohol-dependent patients, funded by the National Institute on Alcohol Abuse and Alcoholism.
Rights and permissions
About this article
Cite this article
McGrath, P.J., Nunes, E.V. & Quitkin, F.M. Treatment of Depression in Alcohol-Dependent Patients. Dis-Manage-Health-Outcomes 2, 22–33 (1997). https://doi.org/10.2165/00115677-199702010-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00115677-199702010-00003